Urogen Pharma Ltd URGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:57 PM EDT
13.45quote price arrow down-0.40 (-2.89%)
Volume
252,796
52 week range
8.69 - 24.13
Loading...
  • Open13.85
  • Day High14.26
  • Day Low13.32
  • Prev Close13.85
  • 52 Week High24.13
  • 52 Week High Date08/15/23
  • 52 Week Low8.69
  • 52 Week Low Date07/26/23

Key Stats

  • Market Cap485.95M
  • Shares Out36.13M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.10
  • YTD % Change-10.13

KEY STATS

  • Open13.85
  • Day High14.26
  • Day Low13.32
  • Prev Close13.85
  • 52 Week High24.13
  • 52 Week High Date08/15/23
  • 52 Week Low8.69
  • 52 Week Low Date07/26/23
  • Market Cap485.95M
  • Shares Out36.13M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.10
  • YTD % Change-10.13

RATIOS/PROFITABILITY

  • EPS (TTM)-3.72
  • P/E (TTM)-3.61
  • Fwd P/E (NTM)-3.72
  • EBITDA (TTM)-64.71M
  • ROE (TTM)-1,481.26%
  • Revenue (TTM)82.713M
  • Gross Margin (TTM)88.68%
  • Net Margin (TTM)-123.61%
  • Debt To Equity (MRQ)-151.12%

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Urogen Pharma Ltd

 

Profile

MORE
UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or...
Arie Belldegrun M.D.
Independent Chairman of the Board
Elizabeth Barrett
President, Chief Executive Officer, Director
Dong Kim
Chief Financial Officer
Address
9 Ha'ta'asiya St
Ra'anana
4365007
Israel

Top Peers

SYMBOLLASTCHG%CHG
EDIT
Editas Medicine Inc
5.70+0.04+0.71%
ALEC
Alector Inc
5.33+0.01+0.19%
FATE
Fate Therapeutics Inc
3.89-0.33-7.82%
ADCT
ADC Therapeutics SA
4.62+0.17+3.82%
TBPH
Theravance Biopharma Inc
9.56-0.04-0.42%